Under the name of disease control, there is a new trend in China to build P3 labs. Seven provinces plan to establish Provincial Center for Disease Control and Prevention. About twenty P3 labs are currently under construction simultaneously.
This information has raised concerns about the Chinese Communist Party’s expanding their covert biochemical weapon program after seeing the damages the CCP-virus has inflicted upon the US.
Many fear that the CCP is turning China into a giant lab to test the lethality and mutation of new viruses for them to find the most effective strand as biochemical weapons. It is holding the world hostage with the viruses because the effective vaccines rely on information about the origin of the virus which is being withheld by the CCP.
According to bioweapons expert Dr. Francis Boyle, all p3 and p4 labs should be banned due to their potential risks
Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush.
Dr. Francis Boyle: They’re complete unsafe. BSL-3 and BSL-4 lab are only designed for research development testing of offense of biological warfare agents. In my opinion, they serve no legitimate purpose at all. They should all be shut down, every one of them.
Please click this link to watch his interview about the CCP virus in Feb, 2020:
Please click here to read the transcript of his interview about the CCP virus in Feb, 2020:
Chinese media: massive P3 lab constructions in China
Aug 11, 2020: Chinese media “Southern Metropolis”
On August 1, the World Health Organization announced that the coronavirus pandemic still constitutes a “public health emergency of international concern”. The pandemic is expected to last for a long time and requires long-term response measures.
This year, the meeting of the Central Deep Reform Commission has mentioned public health system reform three times. Although the documents related to the public health reform at the central level have not yet been issued, local governments have already taken action.
According to the observation of Southern Metropolis reporters, many provinces have already initiated a new round of disease control and public health infrastructure construction. Some provinces have advanced the relocation of new provincial CDCs. It is worth noting that the construction of biosafety level three (P3) laboratories has been included in the planning in various places, and a construction trend has formed.
It is worth noting that the construction of biosafety level three (P3) laboratories has been included in the planning in various places, and a construction trend has formed.
The picture above: on February 25, the staff received the new coronavirus strain for vaccine production that had just arrived from the Zhejiang Provincial Center for Disease Control and Prevention at the delivery window of the P3 laboratory of the Institute for Infectious Disease Control and Prevention of the Chinese Center for Disease Control and Prevention. [Xinhua News Agency]
How many P3 laboratories are there in China?
根据危险度等级，包括传染病原的传染性和危害性，国际上将生物实验室按照生物安全水平分为P1（Protection level 1，相对应BSL-1）、P2、P3和P4四个等级。
According to the level of risk, including the infectivity and hazard of infectious pathogens, biological laboratories are divided into four levels: P1 (Protection level 1, corresponding to BSL-1), P2, P3, and P4 according to the biosafety level.
Taking the novel coronavirus as an example, the P2 laboratory can conduct clinical testing of the new coronavirus, but the isolation of virus strains, vaccine and antibody research, and new pathogen research need to be completed in a higher-level P3 laboratory or P4 laboratory.
After the outbreak of the novel coronavirus, in addition to the China Centers for Disease Control and Prevention, Hubei, Guangdong, Shanghai, Anhui, Zhejiang, Henan, and other provincial CDCs isolated the new crown virus strains in their P3 laboratories.
The official has not published the number and distribution of P3 laboratories nationwide in China, and different sources have provided different information.
According to the Science and Technology Daily, after the SARS epidemic in 2003, our country has successively established more than 40 P3 laboratories and two P4 laboratories. Two P4 laboratories are located in the Wuhan Institute of Virology and Harbin Veterinary Research Institute of the Chinese Academy of Sciences, while the P3 laboratories are mainly concentrated in the national and local CDCs.
According to Ankang, a representative of the National People’s Congress and chairman of Hualan Bio, there are currently 89 domestic biosafety level 3 (BSL-3) laboratories (hereinafter referred to as P3), of which 55 are cell research laboratories.
In general, P3 laboratories can be roughly divided into two categories, one is cell research laboratories, and the other is animal biosafety level three laboratories (ABSL-3).
According to the incomplete statistics from the “Caijing” magazine, there are currently 68 P3 laboratories in mainland China, of which 55 are cell research laboratories (BSL-3) and 13 are infectious animal laboratories (ABSL-3).
In comparison, the more official set of data came from Bai Chunli, Secretary of the Party Leadership Group and Dean of the Chinese Academy of Sciences. He published a signed article “Providing Strong Scientific and Technological Support for Comprehensively Improving the National Biosafety Governance Capability” in the “Flag” magazine in April 2020, revealing that there are currently 81 P3 laboratories in China that have passed the review of the Ministry of Science and Technology and 2 P4 laboratories officially in operation.
“In the United States, there are 12 institutions with P4 laboratories and nearly 1,500 P3 laboratories. The gaps and shortcomings (in China) are obvious.” Bai Chunli mentioned.
The compilation of information in this article was done by Wu Bin, Yang Tianhui. Drawing: He Xin
Many provinces plan to build new provincial CDC
The coronavirus pandemic is still spreading globally, and the domestic disease control system reform has been initiated.
The Southern Metropolis reporters have learned that at present, at least seven provinces, including Yunnan, Beijing, Chongqing, Ningxia, Shanxi, Hunan, and Hainan, are planning to build new provincial CDC sites.
These provinces have generally planned the construction of P3 laboratories in the construction of new provincial CDC sites. Among them, the provincial CDCs in Beijing, Ningxia, Shanxi, Hunan, and Hainan had no P3 laboratories before.
Judging from the current central policies and local public information, making up for the shortcomings of provincial-level disease control facilities and equipment is the first task in the “Public Health Prevention, Control and Treatment Capacity Building Program” officially released after the novel coronavirus pandemic.
The provincial CDC, which did not have a P3 laboratory, may fill the gap after the epidemic.
On May 20, the National Development and Reform Commission, the National Health Commission, and the State Administration of Traditional Chinese Medicine jointly issued the “Public Health Prevention, Control and Treatment Capacity Building Plan”, proposing to comprehensively improve the facilities and equipment of disease control institutions, and realize that at least one of the Safety Level 3 (P3) level laboratory, each prefecture-level city has at least one biosafety level 2 (P2) laboratory, equipped with infectious disease pathogens, health hazards and inspections required for the implementation of national health standards ability.
The plan requires that the national and provincial CDCs focus on improving the ability of infectious disease detection to be “one-shot” and rapid response to sudden infectious disease prevention and control.
The newly planned provincial CDCs generally emphasize the improvement of laboratory testing capabilities.
On July 8, the newly built project of the Hunan Provincial Center for Disease Control and Prevention officially started construction as a major provincial-level construction project. It is understood that the Hunan Provincial Center for Disease Control and Prevention occupies a total area of about 106 mu, with a total investment of about 433 million yuan and a total construction area of about 45,000 square meters.
The construction content is mainly laboratory, including five main buildings of biological laboratory building, physical and chemical laboratory building, toxicology laboratory building, public health service building, logistics complex building, and an independent biosafety three-level laboratory. Inspection, testing and scientific research of highly pathogenic microorganisms including the new coronavirus to meet the needs of the prevention and control of infectious diseases in Hunan. The project is planned to be completed and put into use in the first half of 2022.
The Shanxi Provincial Party Committee and Government also plan to “invest 1 billion to relocate and build a new provincial CDC and P3 laboratory.” The Ningxia Hui Autonomous Region’s CDC relocation project is also underway. The relocation project also plans a biosafety level 3 laboratory, and the local government proposes to start construction within the year.
Although the China Center for Disease Control and Prevention in Beijing has built the country’s largest biosafety three-level laboratory group in Changping Park, it can carry out research on various highly pathogenic microorganisms such as plague, tuberculosis, avian influenza, yellow fever, and Zika related laboratory researches, but there is no P3 lab for Beijing’s municipal medical and health institutions.
“Beijing will focus on strengthening the construction of P3 laboratories in the future and raise the capabilities of the disease prevention and control system to a new level.” Lei Haichao, director of the Beijing Municipal Health Commission, said in May.
Currently, the Beijing Municipal Center for Disease Control and Prevention is planning to build a new site. On July 29, Tan Xuxiang, director of the Beijing Municipal Development and Reform Commission, introduced at the Standing Committee of the Beijing Municipal People’s Congress that in the second half of the year, Beijing will promote the construction of P3 laboratories.
Yunnan invests 9 billion yuan to build a public health system
(Note by GNews editor: Yunnan is home to many diverse species. There is no doubt that it is a “treasure trove” for the CCP to find viruses to “jump” from animals to humans using the gain-of-function technology.)
Tang Wenge, deputy director of the Chongqing Center for Disease Control and Prevention, introduced that the city had established a biosafety three-level laboratory in 2011 with the ability to detect highly pathogenic microorganisms.
At present, Chongqing is also advancing the relocation and construction project of Chongqing CDC. Wang Shichun, director of the Planning and Development Division of the Chongqing Municipal Health Commission, also revealed in May that the city will strengthen the configuration of laboratory facilities and equipment through the construction of the relocation project of the Municipal Center for Disease Control and Prevention in order to carry out the modernization of the disease control system. Virus banks and biosafety level three (P3) laboratories will enhance the ability of infectious disease detection to be the final word.
In contrast, Yunnan Province took more action and acted earlier. The province started a major public health system construction project worth 9 billion yuan at the end of February. On April 10, the Yunnan Provincial Government issued the “Implementation Plan for Improving the Capacity of Major Infectious Disease Treatment and Disease Control Institutions in Yunnan Province.”
According to this plan, Yunnan will relocate to the Provincial Center for Disease Control, Provincial Endemic Disease Prevention and Control Institute, and Provincial Parasitic Disease Prevention and Control Institute. A World Health Organization network laboratory, a biological resource management center, and an international public health cooperation and exchange center, the establishment of the Yunnan Pasteur infectious disease research joint laboratory, and the establishment of the Provincial Academy of Preventive Medicine.
The number of P3 laboratories in Yunnan Province is not behind other provinces, in fact it is in a leading position among all provinces in China.
According to a 2003 report by “Yunnan Daily”, Yunnan Province had established 4 P3 laboratories, which were located in the Kunming Institute of Zoology of the Chinese Academy of Sciences, the former Chengdu Military Medical Research Institute, the Yunnan Entry-Exit Quarantine Bureau and Yunnan Provincial Institute of Epidemiology, 4 laboratories are engaged in different research.
The Yunnan Provincial Center for Disease Control and the Yunnan Provincial Endemic Disease Prevention and Control Institute also have P3 laboratories. Yang Yang, director of the Yunnan Provincial Health Commission, disclosed in May this year that Yunnan had built 9 provincial-level P3 laboratories in 16 prefectures.
In addition to these seven provinces that are relocating to build new provincial CDCs, the CDCs in Guizhou, Shaanxi, Jiangxi, and Heilongjiang are also building the first P3 laboratories in these provinces.
Hainan Province hopes to have its own P3 laboratory
Among the 31 provinces, autonomous regions, and municipalities, Hainan Province is quite special. In addition to Hong Kong, Macao, and Taiwan, China has 11 coastal provinces, and currently only Hainan Province does not have a P3 laboratory.
Among the 18 coastal or border provinces, only Inner Mongolia, Heilongjiang and Hainan currently have no P3 laboratories. In June of this year, the Erlian Customs in the Inner Mongolia Autonomous Region stated that a high-level biosafety laboratory in the public health field with a total investment of 30 million yuan in Inner Mongolia has settled in Erlianhot. The P3 laboratory of the Heilongjiang Provincial Center for Disease Control and Prevention is also under construction. In April this year, Xing Ruoqi, deputy director of the Medical Administration and Management Bureau of the National Health Commission, inspected the laboratory.
Hainan Province is looking forward to the province’s first P3 laboratory with urgency.
In 2016, the Haikou City delegation submitted the “Recommendations on the Construction of Hainan Province Biosafety Level 3 Laboratory” at the two sessions of Hainan Province. According to the proposal, Hainan Island is located in a tropical and subtropical climate, with complex and diverse pathogenic microorganisms, and tropical infectious diseases are more common. At the same time, with the construction of an international tourist island, it is highly open to the outside world, and activities such as the flow of people and logistics are very frequent. It is very likely that various infectious diseases will be imported or even spread. In order to quickly and timely detect highly pathogenic infectious disease pathogens such as Ebola hemorrhagic fever and Middle East respiratory syndrome, a P3 laboratory with a high level of biosafety is required.
In addition, “Hainan is far away from the motherland, and transportation mainly relies on aviation (the civil aviation department has banned civil aviation aircraft from carrying samples of highly pathogenic infectious diseases since 2015), which is not conducive to the transportation of highly pathogenic infectious disease virus samples and affects the epidemic situation of infectious diseases. The timely diagnosis and treatment of the disease, there is also the risk of infection of highly pathogenic pathogens in the process of transportation, preservation, and testing.” The above-mentioned Haikou delegation suggested.
“At present, due to the limitations of the location and environment, the Hainan Provincial Center for Disease Control and Prevention does not have the conditions to build a P3 laboratory, and the Haikou City Center for Disease Control and Prevention has the relevant conditions to build a P3 laboratory. If the provincial level does not yet have the conditions, Haikou City can take the lead Build P3 laboratories to provide services for the province’s infectious disease prevention and control needs.” The Hainan Provincial People’s Congress representative suggested this.
This proposal was handed over to the former Health and Family Planning Commission of Hainan Province to respond.
The official reply is that “The Provincial Center for Disease Control and Prevention’s biosafety level 3 laboratory has been formally established by the National Development and Reform Commission and the Ministry of Science and Technology. It is only limited by factors such as geographic location and laboratory room area. It has the conditions to build a biosafety three-level laboratory. However, the Hainan Health and Family Planning Commission has listed the overall relocation of the Provincial Center for Disease Control and Prevention in the ’13th Five-Year Plan’ project to promote the construction of a biosafety three-level laboratory.”
The reply also pointed out that “the construction cost of the third-level biosafety laboratory is high, the management requirements are strict, and the operation and maintenance cost after completion is also high. According to the opinion of the Haikou Municipal Government, the current conditions for the construction of the P3 laboratory in Haikou are not mature enough.”
Two years later, in 2018, Yang Jun, the president of Hainan Medical College and deputy director of the Hainan Provincial Committee of Education, Science, Health and Sports, submitted a proposal to support Hainan Medical College to establish the “Belt and Road Tropical Medicine Research Center” and build a P3 laboratory.
Yang Jun also proposed that the Belt and Road Tropical Medicine Research Center research pathogenic microorganisms involved in many infectious diseases, and establishes a P3 biosafety laboratory to further improve the center’s public health inspection and testing capabilities and scientific research level and to prevent and control infectious diseases. Emergency response to public health incidents provides strong technical support.
This year, the Health and Family Planning Commission gave the answer: “Considering that the Provincial Center for Disease Control and Prevention will take a long time to relocate and construct, Hainan Medical College has enthusiasm. We do not object to the construction of the first P3 laboratory in our province. “
The latest news is that in March 2020, the Hainan Provincial Development and Reform Commission has approved the feasibility study report on the new project of the Hainan Provincial Center for Disease Control and Prevention, and the public bidding has begun in June.
The prefecture-level city CDC is also planning to build a P3 laboratory
From the perspective of the new round of public health infrastructure in various regions, the provincial CDC is still the main position for the construction of P3 laboratories due to the “one-stop sound” capability for epidemic prevention and control of infectious diseases.
However, the CDC in some cities also proposed the construction of P3 laboratories. For example, Wuhan City in Hubei Province, which was the epicenter of the novel coronavirus, proposed to comprehensively improve the facilities and equipment conditions of disease control institutions. It will build a comprehensive laboratory building, integrated P3 laboratory, and animal laboratory of the Wuhan Centers for Disease Control and Prevention, and rebuild and expand CDCs in various districts, and build a P2 laboratory.
It is reported that the 550-million-yuan comprehensive laboratory building project of Wuhan Centers for Disease Control and Prevention will cover a total land area of about 50 acres with a P3 lab of 3,000 square meters in size.
In this case, Hubei Province CDC and Wuhan City CDC will have P3 laboratories respectively. The P3 laboratory of the Hubei Provincial Center for Disease Control and Prevention was constructed in 2009.
A layout similar to Hubei and Wuhan also appeared in Fujian. At the end of May, the Fuzhou Municipal People’s Government announced that the construction of the new site of the Fuzhou Center for Disease Control and Prevention has completed its plan optimization and will start construction in September. The area of the new CDC site in Fuzhou will be nearly five times that of the original site, including the P3 laboratory. Prior to this, the P3 laboratory of the Fujian Provincial Center for Disease Control and Prevention had obtained the “Qualification Certificate of Highly Pathogenic Pathogenic Microorganism Laboratory” from the former Ministry of Health in 2006.
Shenzhen is also a city with two P3 laboratories. Shenzhen CDC and Shenzhen Third People’s Hospital each have their own P3 laboratories.
In addition, a reporter from Nandu learned from the Jining CDC that Jining, as a prefecture-level city, is also preparing to build a public health inspection and testing center and is also planning to build a P3 laboratory.
There are too few P3 laboratories in Chinese universities
Compared with developed countries, the total number of P3 laboratories in China is relatively few. China’s P3 laboratories are more concentrated in the disease control system, and the number of P3 laboratories in the university system is very small.
“The high-end talents in basic biomedical research in China are mainly concentrated in first-class universities and research institutes, but only a few P3 laboratories are located in universities and research institutions.” Zhang Jingren, deputy dean of the School of Medicine of Tsinghua University, said in an interview in March this year.
One piece of data is that “there are only 8 P3 laboratories capable of conducting research on non-veterinary pathogens in scientific research institutions and universities across the country, and the scale and scope of external cooperation and sharing are extremely limited, which is far from meeting the needs of pathogenic research.” The former director of the Centers for Disease Control and Prevention, Professor Li Liming of Peking University School of Public Health and other experts mentioned in an article recently published in the Chinese Journal of Epidemiology “Recommendations on Reforming and Improving the Prevention, Control and Treatment System for Major Epidemics.”
Take Beijing as an example. Beijing is a center for medical research in China. Although the Chinese Center for Disease Control and the Chinese Academy of Sciences have P3 laboratories in Beijing, “Beijing universities do not have a high-level biosafety laboratory,” Zhang Jingren said.
According to a reporter from “Nandu”, domestic universities that have P3 laboratories include Fudan University, Shanghai Medical University, Southern Medical University, Guangxi Medical University, and Sun Yat-sen University. Wuhan University has a biosafety tertiary animal laboratory (ABSL-3 laboratory) that can conduct large animal experiments.
In November 2019, the Ministry of Science and Technology officially approved the P3 laboratory construction application of the University of Science and Technology of China. Hunan University of Traditional Chinese Medicine is also applying for the P3 laboratory project.
On April 23 this year, the official Weibo of Huazhong University of Science and Technology stated that the Hubei Provincial Development and Reform Commission recently approved a number of projects declared for construction by the school, including emergency prevention and control P3 laboratory. The overall estimated investment of “Huazhong University of Science and Technology Emergency Prevention and Control P3 Laboratory and Testing Center” reached approximately 1.7 billion yuan.
There are also hospitals applying for P3 laboratory construction
In addition, some hospitals affiliated to medical schools have P3 laboratories. The State Key Laboratory of Diagnosis and Treatment of Infectious Diseases where Academician Li Lanjuan works is established in the First Affiliated Hospital of Zhejiang University School of Medicine, where there is a P3 laboratory. The First Affiliated Hospital of China Medical University also has a P3 laboratory.
After the outbreak of the novel coronavirus, Sichuan has accelerated the pace of P3 laboratory construction. Li Weimin, dean of West China Hospital of Sichuan University, revealed that two P3 laboratories in Sichuan are expected to be completed and put into use within one year. One of the P3 laboratories will be built in West China Hospital of Sichuan University and will focus on basic research, pathogenic research and translational research, including vaccine antibody research.
There is no real P3 laboratory in Sichuan at present. Another P3 laboratory will be built in the Sichuan Provincial Center for Disease Control and Prevention, which will be mainly used for pathogen isolation, traceability, and detection to meet the needs of prevention and control. Due to the needs of the pandemic, the estimated completion time of the P3 laboratory of the Sichuan Provincial Center for Disease Control and Prevention has also been advanced.
In addition to the hospitals mentioned above, Guangdong Second People’s Hospital, Shenzhen Third People’s Hospital, and Shanghai Public Health Clinical Center also have their own P3 laboratories.
It is worth mentioning that the P3 laboratory of Shanghai Public Health Center may be one of the biosafety laboratories with the highest annual utilization rate in the country. Professor Zhang Yongzhen’s team from Shanghai Public Health Center has discovered more than 2,000 types of viruses among more than 6,000 types of viruses worldwide. The laboratory has contributed 3 of the 14 orders classified by the International Commission for Virology Classification.
Zhu Tongyu, the director of the Shanghai Public Health Center, said in an interview with Nandu reporters in May this year that the Shanghai Public Health Center not only focuses on clinical treatment but also has strong scientific research capabilities. The Shanghai Public Health Center has more than 250 doctors and more than 150 scientific researchers.
In the first four months of this year, the hospital’s patent transfer income exceeded 300 million, of which 250 million was the conversion of patents related to drug research related to the pandemic, and another 50 million was the conversion of tuberculosis research results. The research investment of hospitals accounts for 5.7%, and the research investment of general hospitals is only about 1%-2%.
Li Liming, a professor at the School of Public Health of Peking University, and other experts also suggested that in order to meet the urgent need for research on the etiology of emerging infectious diseases and at the same time do a good job in biosafety protection, it is necessary to rationalize the layout, make overall planning, increase the number of P3 laboratories, and strive to become key diseases-control institutions, scientific research institutions, high-level comprehensive or specialized hospitals, and high-level medical schools that undertake national tasks are equipped with P3 laboratories, while appropriately increasing the number of P4 laboratories.
After this round of the novel coronavirus pandemic, the construction of the P3 laboratory in the hospital system is also on the agenda.
Nanjing Second Hospital has started the construction of P3 laboratory. In March, the Nanjing Municipal Science and Technology Bureau visited the hospital branch for investigation. Prior to this, the hospital also invited experts to demonstrate the feasibility of the construction.
Recently, the construction of a major epidemic treatment base in Jiangxi Province was approved by the National Development and Reform Commission and will be located in the Xianghu District of the First Affiliated Hospital of Nanchang University. The base will build the first P3 laboratory in Jiangxi Province.
南都记者 吴斌 宋承翰 胡明山 实习记者 杨天慧 发自北京
Southern Metropolis reporter Wu Bin Song Chenghan Hu Mingshan Trainee reporter Yang Tianhui from Beijing
May 25, 2020: 广东规划建设25-30家P3实验室，5年内有望建成P4
2020年05月25日 14:23 1557 次阅读 稿源：澎湃新闻
Guangdong plans to build 25-30 P3 laboratories, and P4 is expected to be built within 5 years
May 25, 2020 14:23
In the prevention and control of the pandemic, the P3 laboratory has played an important role. The isolation of virus strains, the study of virus invasion mechanisms, mutation tracking, vaccine research and development, and drug screening all need to be carried out in the P3 laboratory. At the National Two Sessions, the construction of the P3 laboratory became a hot topic of discussion among the delegates.
In view of the current lack of high-level biosafety laboratories in Guangdong, many representatives have called on Guangdong to increase the layout of P3 and P4 laboratories.
Wang Ruijun, deputy to the National People’s Congress, director of the Guangdong Provincial Department of Science and Technology, and mayor of Shaoguan City, revealed that the Guangdong Provincial Department of Science and Technology has formed a construction plan, planning to build 25 to 30 P3 laboratories to meet the basic P3 laboratory needs, at least one P4 laboratory will be built within 5 years.”
The “shortage” in Guangdong P3 laboratory is very obvious.
According to the infectiousness and hazard of infectious pathogens, biosafety laboratories are divided into four biosafety levels, P1, P2, P3, and P4. The higher the level, the higher the protection level.
“From SARS, H1N1, MERS, Ebola, H5N7 and other viruses to new coronaviruses, all relevant research needs to be carried out in P3 or P4 laboratories,” said Zhou Haibo, deputy to the National People’s Congress and secretary of the Party Committee of Qingyuan People’s Hospital. In this new crown pneumonia epidemic, the isolation of novel coronavirus strains, the study of virus invasion mechanisms, mutation tracking, vaccine research and development, and drug screening all require the platform of the P3 laboratory.
At present, our country’s P3 laboratories are generally distributed in institutions such as universities, scientific research institutions, and customs. The Third People’s Hospital of Shenzhen is currently one of the 4 hospitals in our country that has a P3 laboratory that can monitor the virus dynamically.
After the outbreak, the hospital’s P3 laboratory was open 24 hours a day, brightly lit day and night, and carried out high-risk clinical sample detection, virus isolation, culture identification, and testing. “The P3 laboratory played a key role in our response to the epidemic,” said Zhang Zheng, director of the hospital’s P3 laboratory.
Compared with the United States and other countries in the world, China’s P3 and P4 laboratories are seriously insufficient in number and scale.
“Our shortcomings are very prominent.” Wang Ruijun pointed out that there are nearly 1,500 P3 laboratories in the United States, widely available in medical institutions or medical schools. “In comparison, there is a shortage of high-level biosafety laboratories in China and especially in Guangdong.”
He revealed that at present, there are only two P4 laboratories in the country, namely the Wuhan Institute of Virology of the Chinese Academy of Sciences and the Harbin Institute of Veterinary Research. The latter can only do animal research. Guangdong has not yet had a P4 laboratory, and there is no high-level P3 laboratory that can do large-scale animal experiments. There are only 5 P3 laboratories that are not high enough.
As the “national team” for the treatment and research of respiratory infectious diseases, the team of Academician Zhong Nanshan has never had an independent P3 laboratory. During this pandemic, the National Key Laboratory of Highly Pathogenic Microbiology Laboratory used by the team is the P3 laboratory jointly established by the State Key Laboratory of Respiratory Diseases and the Guangzhou Customs Technology Center.
“The God of Wealth follows the God of Plague” is an old saying in the field of disease control. In this round of reforms, the public health sector is more concerned about the sustainability of local support for investment in public health projects worth tens of billions of yuan. When talking about the SARS epidemic last year, Qi Xiaoqiu, the former director of the Ministry of Health for Disease Control, said: “When SARS was here, and perhaps the leaders have paid attention to it for a while. After SARS is gone, some local leaders will gradually not pay attention to it. In the final analysis, it is that public health has not gained enough attention.”